Origin SPAC Presentation Deck

Operational Valuation Illustrative valuation references Key Metrics Sustained growth outlook ESG Tech component Secured revenue CY'20E-22E revenue CAGR CY'21E EBITDA margin EV/CY'21E sales/ EV/CY'22E sales EV/CY'21E EBITDA/ EV/CY'22E EBITDA ORIGIN I L Low High High High 161% (¹) 36% (2) High I I 1.2x/0.7x I 13.4x / 1.7x Represents 2026E/ 2027E multiples Specialty Chemicals AALBEMARLE DSM Low novozymes -1 High Low / Medium CRODA --L Source: Origin Materials Consolidated Financials; company projections based on company filings and FactSet as of January 29, 2021. Note: Company statistics represent mean statistics. 1. CY'24-CY'26E 2. CY'26E. Medium Medium 7% 28% 5.7x/5.4x 20.6x/18.7x Biochemicals/ Biomaterials avantium Corbion Lonza 7-- Low CODEXIS PROTEIN ENGINEERING EXPERTS danimer 19% scientific Medium / High Medium / High Medium / High 21% High 13.4x/9.8x 30.3x/ 21.6x(3) Disruptive technology BEYOND MEAT PLUG POWER T TESLA Low D Desktop Metal High High Medium / High 45%(4) 3. Danimer EV / EBITDA multiples based on 2023E / 2024E from October 2020 Investor Presentation. 4. Plug Power and Desktop Metal CAGR based on 2023E-2025E, margins based on 2024E. 5. Plug Power and Desktop Metal multiples based on 2024E / 2025E. sunrun 22%(4) High 17.0x/ 12.8x(5) 109.7x/65.4x(5) ORIGIN 36

View entire presentation